Eam Investors, LLC Ligand Pharmaceuticals Inc Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $1.8 Million - $3.81 Million	-14,000 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$211.18 - $274.49 $225,117 - $292,606	-1,066 Reduced 7.08%	14,000 $3.84 Million
Q2 2018 Aug 03, 2018	SELL	$150.77 - $207.98 $897,232 - $1.24 Million	-5,951 Reduced 28.32%	15,066 $3.12 Million
Q1 2018 May 14, 2018	BUY	$138.63 - $182.62 $2.91 Million - $3.84 Million	21,017 New	21,017 $3.47 Million

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.86B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.